UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis

Leukemia, 2016-12, Vol.30 (12), p.2385-2395

2016

Volltextzugriff (PDF)

Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial

Bone marrow transplantation (Basingstoke), 2011-09, Vol.46 (9), p.1245-1255

2011

Volltextzugriff (PDF)

Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study

Hematological oncology, 2023-06, Vol.41 (S2), p.416-418

2023

Volltextzugriff (PDF)

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland

Hematological oncology, 2021-04, Vol.39 (2), p.196-204

2021

Volltextzugriff (PDF)

R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY DIAGNOSED HIGH‐RISK BURKITT LYMPHOMA: FINAL RESULTS OF A MULTI‐CENTER RANDOMIZED HOVON/SAKK TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.50-51

2023

Volltextzugriff (PDF)

Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.334-336

2017

Volltextzugriff (PDF)

Human Neoplasms Elicit Multiple Specific Immune Responses in the Autologous Host

Proceedings of the National Academy of Sciences - PNAS, 1995-12, Vol.92 (25), p.11810-11813

1995

Volltextzugriff (PDF)

CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 60 YEARS TREATED IN SWITZERLAND OVER THE LAST 17 YEARS

Hematological oncology, 2019-06, Vol.37 (S2), p.289-290

2019

Volltextzugriff (PDF)

Übersicht – Personalisierte Therapiestrategien bei Lymphomen

TumorDiagnostik & Therapie, 2016-09, Vol.37 (7), p.380-383

2016

Volltextzugriff (PDF)

2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)

European journal of cancer (1990), 2015-09, Vol.51, p.S473-S473

2015

Volltextzugriff (PDF)

Multicentric Castleman’s disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man

Infection, 2012-04, Vol.40 (2), p.203-205

2012

Volltextzugriff (PDF)

How Useful is PET/CT Imaging in the Management of Post‐Transplant Lymphoproliferative Disease After Liver Transplantation?

American journal of transplantation, 2006-07, Vol.6 (7), p.1731-1736

2006

Volltextzugriff (PDF)

Association of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel

Annals of oncology, 2018-10, Vol.29, p.viii280-viii281

2018

Volltextzugriff (PDF)

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

The New England journal of medicine, 2012-05, Vol.366 (19), p.1759-1769

2012

Volltextzugriff (PDF)

Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1418

2024

Volltextzugriff (PDF)

A0529 - Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1418-S1418

2024

Volltextzugriff (PDF)

New drug treatment possibilities in castration resistant prostate carcinoma

Praxis (Bern. 1994), 2012-09, Vol.101 (18), p.1143

2012

Volltextzugriff (PDF)

A0535 - Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1424-S1424

2024

Volltextzugriff (PDF)

Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

European urology, 2024-03, Vol.85, p.S1424

2024

Volltextzugriff (PDF)

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma

Expert review of anticancer therapy, 2013-09, Vol.13 (9), p.1021-1033

2013

Volltextzugriff (PDF)

2571 A high baseline neutrophil count may predict poor prognostic outcome in mCRPC: A post-hoc analysis of the TROPIC phase III trial

European journal of cancer (1990), 2015-09, Vol.51, p.S501-S501

2015

Volltextzugriff (PDF)

Onkologie: Licht im Dunkel beim schwarzen Hautkrebs

Swiss medical forum, 2012-01, Vol.12 (1)

2012

Volltextzugriff (PDF)

Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort

Swiss medical weekly, 2010-07

2010

Volltextzugriff (PDF)

Selective Intra-arterial Chemotherapy with Floxuridine as Second- or Third-Line Approach in Patients with Unresectable Colorectal Liver Metastases

Annals of surgical oncology, 2011-07, Vol.18 (7), p.1924-1931

2011

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(108)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis

Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial

Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland

R‐CODOX‐M/R‐IVAC VERSUS DA‐EPOCH‐R IN PATIENTS WITH NEWLY DIAGNOSED HIGH‐RISK BURKITT LYMPHOMA: FINAL RESULTS OF A MULTI‐CENTER RANDOMIZED HOVON/SAKK TRIAL

Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse

Human Neoplasms Elicit Multiple Specific Immune Responses in the Autologous Host

CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH HODGKIN'S LYMPHOMA OLDER THAN 60 YEARS TREATED IN SWITZERLAND OVER THE LAST 17 YEARS

Übersicht – Personalisierte Therapiestrategien bei Lymphomen

2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11)

Multicentric Castleman’s disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man

How Useful is PET/CT Imaging in the Management of Post‐Transplant Lymphoproliferative Disease After Liver Transplantation?

Association of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer

A0529 - Novel patient-derived organoid xenograft models emulate molecular, functional, and clinical features of advanced prostate cancer

New drug treatment possibilities in castration resistant prostate carcinoma

A0535 - Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

Cell-Free DNA genomic profiling and its clinical implementation in advanced prostate cancer

The clinical potential of temsirolimus in second or later lines of treatment for metastatic renal cell carcinoma

2571 A high baseline neutrophil count may predict poor prognostic outcome in mCRPC: A post-hoc analysis of the TROPIC phase III trial

Onkologie: Licht im Dunkel beim schwarzen Hautkrebs

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort

Selective Intra-arterial Chemotherapy with Floxuridine as Second- or Third-Line Approach in Patients with Unresectable Colorectal Liver Metastases

Aktive Filter

Suchergebnisse filtern